Cargando…
Chromosome 17 copy number changes in male breast cancer
BACKGROUND: Overall, HER2-amplified female breast cancer (FBC) is associated with a high grade, an aggressive phenotype and a poor prognosis. In male breast cancer (MBC) amplification of HER2, located on chromosome 17, occurs at a lower frequency than in FBC, where it is part of complex rearrangemen...
Autores principales: | Lacle, Miangela M., Moelans, Cathy B., Kornegoor, Robert, van der Pol, Carmen, Witkamp, Arjen J., van der Wall, Elsken, Rueschoff, Josef, Buerger, Horst, van Diest, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445249/ https://www.ncbi.nlm.nih.gov/pubmed/25906114 http://dx.doi.org/10.1007/s13402-015-0227-7 |
Ejemplares similares
-
Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer
por: Lacle, Miangela M., et al.
Publicado: (2013) -
Prognostic models in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2016) -
Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer
por: Moelans, Cathy B., et al.
Publicado: (2018) -
Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value
por: Lacle, Miangela M., et al.
Publicado: (2015) -
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer
por: Suelmann, B. B. M., et al.
Publicado: (2022)